<Disease><Name>PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES (PASNA)</Name><Synonym>APA WITH SEIZURES AND NEUROLOGICAL ABNORMALITIES</Synonym><OMIM><Number>615474</Number><URL>http://omim.org/entry/615474</URL></OMIM><Orphanet><Number>369929</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=369929</URL></Orphanet><Protein><Number>Voltage-dependent L-type calcium channel subunit alpha-1D</Number><URL>https://www.uniprot.org/uniprot/Q01668</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>3p21.1</Gene><ICD>E26.0</ICD><Summary>rare;autosomal dominant;mutation in the CACNA1D gene</Summary><Symptoms><symtomp><id>3424</id><symptom>abnormal movement</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2241</id><symptom>athetosis</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2449</id><symptom>heart involvement</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3248</id><symptom>hyperaldosteronism</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2296</id><symptom>hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3502</id><symptom>hypokalemia / hypokalaemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2066</id><symptom>metabolic alkalosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3696</id><symptom>pulmonary hypertension</symptom><category>CARDIOVASCULAR SYSTEM | LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2236</id><symptom>urolithiasis, nephrolithiasis, kidney stones</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2150</id><symptom>ventricular septal defect</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>798</id><name>Aldosterone</name><specimen>plasma</specimen><value>increased</value><min>5.00</min><max>60.00</max><unit>ng/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>799</id><name>Aldosterone</name><specimen>plasma</specimen><value>increased</value><min>1.00</min><max>160.00</max><unit>ng/dl</unit><age>infant</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6172</id><title>A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia</title><author>Flanagan SE,</author><journal>Pediatr Diabetes</journal><year>2017</year><book /><volume>18</volume><number>4</number><pages>320-323</pages><co_aut>et al.</co_aut></literature><literature><id>6173</id><title>Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism</title><author>Scholl UI,</author><journal>Nat Genet</journal><year>2013</year><book /><volume>45</volume><number>9</number><pages>1050-1054</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>